Doctor profile · Federal record
Dr. Freddy Espinoza, FNP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Nurse Practitioner · Primary Care Nurse Practitioner · Fresno, CA
- NPI 1124440524
- Accepts Medicare
- MIPS 80.2 / 100 · 2023
- 13 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
7085 N Chestnut Ave Ste 101
Fresno, CA 937200353
(559) 323-9236
fax (559) 323-0294 - Mailing address
-
2625 E Divisadero St
Fresno, CA 937211431
Credentials & registration
- NPI registered
- January 2014 — 12 yrs on file
- Profile last updated
- January 28, 2021
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- California #95000246
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124440524. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
350
Distinct HCPCS
5
Medicare allowed
$30,574
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 181 | 68 | $112 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 89 | 34 | $30 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 40 | 40 | $146 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 21 | 13 | $74 | |
83037 |
Hemoglobin a1c level, by device for home use | 19 | 18 | $10 |
In context: peer comparison
Among 35 peers in Fresno Family Nurse Practitioner, average services per provider: 136. This provider delivers 2.6× the peer median.Open Payments
Industry payments received
All-time total
$5,095
Transactions
157
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk INC | 27 | $938.46 | |
| Lilly USA, LLC | 32 | $839.92 | |
| Amgen INC. | 23 | $792.23 | |
| Bayer Healthcare Pharmaceuticals INC. | 9 | $344.04 | |
| Abbott Laboratories | 10 | $329.22 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 7 | $232.92 | |
| Xeris Pharmaceuticals, INC. | 8 | $231.47 | |
| Esperion Therapeutics, INC. | 4 | $155.25 | |
| Antares Pharma, INC. | 10 | $149.10 | |
| Alexion Pharmaceuticals, INC. | 6 | $143.70 | |
| Dexcom, INC. | 6 | $133.94 | |
| Sanofi-Aventis U.S. LLC | 4 | $96.39 | |
| Ascensia Diabetes Care US INC. | 4 | $94.21 | |
| Ultragenyx Pharmaceutical INC. | 4 | $83.61 | |
| Recordati_Rare_Diseases_INC. | 3 | $81.83 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
615
Patients
189
Total drug cost
$525,691
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 120 | 39 | $163,617 |
| Levothyroxine Sodium | Generic | 62 | 26 | $1,227 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 61 | 21 | $72,743 |
| Metformin Hcl | Generic | 47 | 23 | $910 |
| Rybelsus (Semaglutide) | Brand | 45 | 20 | $78,266 |
| Jardiance (Empagliflozin) | Brand | 43 | 17 | $76,965 |
| Trulicity (Dulaglutide) | Brand | 43 | 0 | $54,670 |
| Mounjaro (Tirzepatide) | Brand | 42 | 0 | $49,878 |
| Pioglitazone Hcl | Generic | 38 | 19 | $1,011 |
| Atorvastatin Calcium | Generic | 24 | 11 | $439 |
Frequently asked questions
What is Dr. Freddy Espinoza's medical specialty?
Dr. Freddy Espinoza practices Family Nurse Practitioner in Fresno, CA.
Where does Dr. Freddy Espinoza practice?
Dr. Freddy Espinoza practices at 7085 N Chestnut Ave Ste 101, Fresno, CA 937200353. Office phone: 5593239236.
What is Dr. Freddy Espinoza's NPI?
Dr. Freddy Espinoza's National Provider Identifier (NPI) is 1124440524, issued by NPPES.
Does Dr. Freddy Espinoza accept Medicare assignment?
Yes. Dr. Freddy Espinoza accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Freddy Espinoza commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); New patient office or other outpatient visit (HCPCS 99204). Source: CMS Medicare Physician & Other Practitioners file.